Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
NCT03255473Phase 2Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Aug 2017
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in sudden sensorineural hearing loss (SSHL), sponsored by University of Colorado Denver. Planned start Aug 2017; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT03255473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255473.